Goldman Sachs’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
|
|||||
|
2025
Q1 | $12.6M | Sell |
|
|||||
|
2024
Q4 | $30.4M | Sell |
|
|||||
|
2024
Q3 | $62.4M | Buy |
|
|||||
|
2024
Q2 | $32.4M | Buy |
|
|||||
|
2024
Q1 | $23.7M | Buy |
|
|||||
|
2023
Q4 | $17.4M | Buy |
|
|||||
|
2023
Q3 | $11.3M | Sell |
|
|||||
|
2023
Q2 | $15M | Buy |
|
|||||
|
2023
Q1 | $13M | Sell |
|
|||||
|
2022
Q4 | $20M | Sell |
|
|||||
|
2022
Q3 | $18.7M | Buy |
|
|||||
|
2022
Q2 | $11.9M | Buy |
|
|||||
|
2022
Q1 | $10.3M | Buy |
|
|||||
|
2021
Q4 | $9.82M | Sell |
|
|||||
|
2021
Q3 | $16.6M | Sell |
|
|||||
|
2021
Q2 | $11.3M | Sell |
|
|||||
|
2021
Q1 | $9.66M | Sell |
|
|||||
|
2020
Q4 | $11.3M | Buy |
|
|||||
|
2020
Q3 | $1.53M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $10K | Sell |
|
|||||
|
2018
Q3 | $238K | Sell |
|
|||||
|
2018
Q2 | $1.01M | Buy |
|
|||||
|
2018
Q1 | $1.07M | Buy |
|
|||||
|
2017
Q4 | $825K | Sell |
|
|||||
|
2017
Q3 | $1.09M | Buy |
|
|||||
|
2017
Q2 | $537K | Sell |
|
|||||
|
2017
Q1 | $1.01M | Buy |
|
|||||
|
2016
Q4 | $984K | Buy |
|
|||||
|
2016
Q3 | $858K | Sell |
|
|||||
|
2016
Q2 | $1.89M | Sell |
|
|||||
|
2016
Q1 | $1.7M | Buy |
|
|||||
|
2015
Q4 | $4.69M | Buy |
|
|||||
|
2015
Q3 | $2.68M | Sell |
|
|||||
|
2015
Q2 | $9.58M | Buy |
|
|||||
|
2015
Q1 | $8.72M | Sell |
|
|||||
|
2014
Q4 | $6.18M | Buy |
|
|||||
|
2014
Q3 | $3.3M | Buy |
|
|||||
|
2014
Q2 | $3.65M | Sell |
|
|||||
|
2014
Q1 | $4.09M | Buy |
|
|||||
|
2013
Q4 | $5.35M | Buy |
|
|||||
|
2013
Q3 | $6.81M | Buy |
|
|||||
|
2013
Q2 | $1.99M | Buy |
|